AMERICAN SOCIETY FOR RADIATION ONCOLOGY lobbying for AMERICAN SOCIETY FOR RADIATION ONCOLOGY

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Expenses

$159,587.00

What this organization spent lobbying with its own staff. Reported using C: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Virginia

Official filing document

Government bodies contacted 9

Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Natl Institutes of Health (NIH)
Nuclear Regulatory Commission (NRC)
Office of Management & Budget (OMB)
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 3

HR 2120
ROCR Value Based Program Act
S 1031
ROCR Value Based Program Act
HR 879
Medicare Patient Access and Practice Stabilization Act of 2025

Lobbying activity 4

Health Issues

FY2026 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support for NRC Commissioner nominee to have medical background Radiation Oncology reimbursement Policy initiatives designed to increase transparency in the prior authorization process Efforts to educate legislators about unintended consequences associated with rate setting for health care services Preserve current training and experience requirements for radiopharmaceuticals Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations

Medicare/Medicaid

Oppose restrictive prior authorization practices Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates Support for H.R. 2120 and S. 1031, a bill to modernize radiation oncology reimbursement - The Radiation Oncology Case Rate Value Based Program Act of 2025 Support for H.R. 879, to fix Medicare Physician Fee Schedule's physician payment reimbursement cuts in 2025

Homeland Security

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC)

Budget/Appropriations

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for fiscal year 2025 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Support for ARPA-H to support innovative cancer treatments Support for initiatives to increase diversity in clinical trials Support for DOD lung cancer research program funding